Scribe 2026 Privacy Policy Site by Bunsen

scribetx.com

scribetx.com • 201-500 employees

201-500 employees

Actively hiring

Financial Services

Biotechnology

Health Care

As featured in

Axios

Forbes

eLife

Overview

News

Salaries

Products

People

Growth

Offices

Financials

Overview

We’re unlocking the future of medicine with CRISPR-based therapeutics that are safe and effective enough to transform everyone's lifetime risk for disease.

News

News nytimes.com 27 days ago

Media Can Geneticists Fight Disease by Targeting 'Nurture' Instead of 'Nature'? September 8, 2026 The New York Times Read Now Read more

Report

News barrons.com 3 months ago

Media Scribe's Genetic Editing Aims to Prevent Heart Attacks July 27, 2026 Barron's Read Now Read more

Report

News axios.com 3 months ago

Media Scribe prices upsized IPO before producing human efficacy data July 24, 2026 Axios Read Now Read more

Report

News bloomberg.com 3 months ago

Media Eli Lilly-Backed Scribe Therapeutics Soars 44 After IPO July 24, 2026 Bloomberg News Read Now Read more

Report

News fiercebiotech.com 3 months ago

Media Scribe records upsized 129M IPO to bankroll lipid-lowering genetic meds July 24, 2026 Fierce Biotech Read Now Read more

Report

News economist.com 1 year ago

Epigenetic editors are a gentler form of gene editing February 24, 2025 The Economist Read more

Report

News forbes.com 3 years ago

This Scientist Is Building Custom Gene-Editing Tools Read more

Report

News academic.oup.com 9 years ago

Publication Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery March 2, 2017 Nucleic Acids Research Read Now Read more

Report

News elifesciences.org 12 years ago

Publication Enhanced homology-directed human genome engineering by controlled timing of CRISPRCas9 delivery December 15, 2014 eLife Read Now Read more

Report